MARSHALL WACE, LLP

Position in GILD — Gilead Sciences, Inc.

CIK 1318757 LONDON, X0

Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$25,858,892

-$296,157,582 QoQ

Shares Held

204,677

-91.1% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#293

of 2,275 holders

Holding Since

Mar 2020

21 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2026

CallValue

$25,268

CallShares

200

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $2,303,425,127 across 13 Drug Manufacturers - General names. GILD ranks #8 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,989,537	$759,252,709
2	ABBV	AbbVie Inc.	2,990,512	$752,532,439
3	LLY	ELI LILLY & Co	334,637	$401,373,688
4	AZN	Astrazeneca PLC	841,164	$159,501,517
5	NVO	Novo Nordisk A S	1,707,104	$81,838,564
6	NVS	Novartis AG	330,061	$51,727,159
7	AMGN	Amgen Inc	99,402	$35,995,452
8	GILD	Gilead Sciences, Inc. This page	204,677	$25,858,892

All Filings in GILD

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,268	200	0.0%	Call	Other	2026-08-13
2026-06-30	$25,858,892	204,677	-91.1%	Shares	Other	2026-08-13
2026-03-31	$322,016,474	2,310,515	+191.2%	Shares	Other	2026-05-15
2025-12-31	$97,380,074	793,385	-58.3%	Shares	Other	2026-02-13
2025-12-31	$12,274	100	0.0%	Put	Other	2026-02-13
2025-12-31	$24,548	200	-99.8%	Call	Other	2026-02-13
2025-09-30	$11,100	100	-99.9%	Put	Other	2025-11-13
2025-09-30	$211,064,280	1,901,480	-2.5%	Shares	Other	2025-11-13
2025-06-30	$216,286,637	1,950,813	+152.1%	Shares	Other	2025-08-13
2025-03-31	$86,711,796	773,867	-36.4%	Shares	Other	2025-05-15
2024-12-31	$112,395,630	1,216,798	+18.9%	Shares	Other	2025-02-13
2024-09-30	$85,824,073	1,023,665	+749.4%	Shares	Other	2024-11-14
2024-06-30	$8,268,602	120,516	+207.5%	Shares	Other	2024-08-14
2023-06-30	$3,020,373	39,190	-99.2%	Shares	Other	2023-08-14
2023-06-30	$9,803,304	127,200	+86.2%	Call	Other	2023-08-14
2023-06-30	$14,735,784	191,200	+411.2%	Put	Other	2023-08-14
2023-03-31	$421,039,727	5,074,602	+14.6%	Shares	Other	2023-05-15
2022-12-31	$380,309,489	4,429,930	+31.6%	Shares	Other	2023-02-14
2022-12-31	$3,210,790	37,400	+8.7%	Put	Other	2023-02-14
2022-12-31	$5,863,555	68,300	+8.6%	Call	Other	2023-02-14
2022-09-30	$3,880,301	62,900	-69.3%	Call	Other	2022-11-14
2022-09-30	$207,583,332	3,364,943	+12.8%	Shares	Other	2022-11-14
2022-09-30	$2,122,136	34,400	-42.3%	Put	Other	2022-11-14
2022-06-30	$184,407,044	2,983,450	+19.8%	Shares	Other	2022-08-15
2022-03-31	$148,056,597	2,490,439	+8831.4%	Shares	Other	2022-05-16
2021-12-31	$4,327,556	59,600	-43.4%	Put	Other	2022-02-14
2021-12-31	$14,885,050	205,000	-31.4%	Call	Other	2022-02-14
2021-12-31	$2,024,657	27,884	+190.5%	Shares	Other	2022-02-14
2021-09-30	$7,355,205	105,300	+542.1%	Put	Sole	2021-11-15
2021-09-30	$670,560	9,600	-92.3%	Shares	Sole	2021-11-15
2021-09-30	$20,878,165	298,900	+1816.0%	Call	Sole	2021-11-15
2021-06-30	$8,545,250	124,096	+156.1%	Shares	Sole	2021-08-13
2021-06-30	$1,074,216	15,600	-61.1%	Call	Sole	2021-08-13
2021-06-30	$1,129,304	16,400	—	Put	Sole	2021-08-13
2021-03-31	$3,131,905	48,459	-45.8%	Shares	Sole	2021-05-17
2021-03-31	$2,591,663	40,100	—	Call	Sole	2021-05-17
2020-12-31	$5,204,132	89,326	+2251.3%	Shares	Sole	2021-02-16
2020-03-31	$284,013	3,799	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.